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Coordinately increased lysozymuria and lysosomal enzymuria
induced by maleic acid
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Coordinately increased lysozymuria and lysosomal cnzymuria induced
by maleic acid. During the acute renal tubular dysfunction of Fanconi
syndrome and type 2 renal tubular acidosis (FS/RTA2) induced by
maleic acid in the unanesthetized dog, we observed: I) 30 minutes after
the onset of FS/RTA2, the urinary excretion of lysosomal enzymes,
N-aeetyl-$-glueosaminidase (NAG), /3-glucuronidase (/3-glue) and /3-
galactosidasc (/3-galac), increased simultaneously with the anticipated
increase in renal clearance of lysozyme; 2) the seventies of all these
hyperenzymurias increased rapidly, progressively, and in parallel, all
reaching a peak some 60 to 80 minutes after their onset; 3) thereafter,
while the FS/RTA2 continued undiminished in severity, the severity of
the hyperenzymurias decreased rapidly, greatly, progressively, and in
parallel; and 4) sodium phosphate toading strikingly attenuated the
FS/RTA2 and the hyperenzymurias. Thus, the maleic acid—induced
FS/RTA2 is attended by an acute reversible—complex derangement in
the renat tubular processing of proteins that: a) affects not only
lysozyme which is normally filtered, but also NAG and other lysosomal
enzymes, which are not; and b) is to some extent functionally separable
from that of FS/RTA2. The findings suggest that the derangements in
renal processing of lysozyme and lysosomal enzymes are linked, and
that a phosphate—dependent metabolic abnormality in the proximal
tubule can participate in the pathogenesis of both these derangements
and the FS/RTA2.
Whether occurring as part of either a chronic clinical disorder
or as an acute experimental disorder, the complex proximal
renal tubular dysfunction of Fanconi syndrome that includes
type 2 renal tubular acidosis (FS/RTA2) also includes a reduc-
tion in renal tubular reabsorption of lysozyme and other small
molecular weight proteins that are normally readily filtered by
the glomerulus [1—5]. These proteins are normally almost com-
pletely reabsorbed in the proximal renal tubule by a vacuolar
transport system in which they are endocytosed from the
tubular lumen and conveyed in vacuoles to lysosomes, where
they are enzymatically degraded [6—91. In the experimental
model of FS/RTA2 induced acutely in the rat given maleic acid,
Christensen and Maunsbach reported the direct histochemical
demonstration of impaired tubular uptake and vacuolar trans-
port of lysozyme to lysosomes, an impairment which occurred
restrictively in the proximal tubule and within 20 minutes of
administering maleic acid [101.
Received for publication December 16, 1985
and in revised form June 5, 1986
© 1986 by the International Society of Nephrology
Also observed whenever sought in FS/RTA2 is the phenom-
enon of increased urinary excretion of lysosomal enzymes,
such as N-acetyl-/3-glucosaminidase (NAG) [11—131. Though
too large to be normally filtered by the glomerulus, these
proteins normally occur in the kidney, predominantly in
lysosomes of the proximal convoluted tubule in whose cells
they are synthesized [14, 15]. Although an increased urinary
excretion of NAG and other lysosomal enzymes is generally
inferred to reflect "damage" or "injury" to the renal tubule
[16—18], the phenomenon can occur in the absence of renal
damage through the mechanism of exocytosis [191. in some
cells, the process of endocytosis is dynamically coupled to that
of exocytosis [20—25] and inhibition of endocytosis can be
attended by accelerated exocytosis of lysosomal enzymes [26,
27]. Thus, in FS/RTA2 the combination of increased urinary
excretion of both lysozyme and lysosomal enzymes could
reflect a complex proximal tubular disorder of vacuolar trans-
port that affects both endocytosis and exocytosis. in the current
study, we report evidence in support of this hypothesis in the
experimental model of FS/RTA2 induced by maleic acid in the
unanesthetized trained dog. We find that the predictably in-
duced lysozymunia is attended by simultaneous and coordinate
increases in urinary excretion of lysosomal enzymes, and that
the time course of the lysozymuria is indistinguishable from that
of the lysosomal hyperenzymuria, yet distinct from that of the
FS/RTA2: the hyperenzymurias, which began after the onset of
FS/RTA2, rapidly increased to a peak of severity, then rapidly
decreased, while the dysfunction of FS/RTA2 persisted
undiminished in severity. The current study also demonstrates
that phosphate loading, which has recently been shown to
attenuate the severity of the maleic acid—induced FS/RTA2,
also attenuates the severity of both the lysozymuria and the
lysosomal hyperenzymuria.
Methods
Twenty—three renal clearance studies were performed with-
out anesthesia on eight trained female mongrel dogs weighing 20
to 24 kg. Food was withheld for 18 hours before and throughout
each study, but free access to water was provided throughout.
At least two to three weeks elapsed between studies on the
same animal. At the beginning of each study, indwelling cath-
eters were placed in a foreleg and hindleg vein for infusion of
solution and for blood sampling, respectively. Throughout each
study, inulin was intravenously administered to maintain a
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plasma concentration of approximately 25 mg/dl. Water diuresis
was initiated by the intravenous administration of 3.5% glucose
in water solution at a rate of 1 mI/kg body weight per minute for
40 minutes. Thereafter, the infusion rate was adjusted to match
or slightly exceed urinary output. Urine was collected under
mineral oil via an indwelling bladder catheter. When the urinary
osmolality had decreased to values less than 60 mOsm/kg water
and urine flow rate was stable, three to five 10-minute control
clearance periods were obtained. Immediately thereafter, one
of the following protocols were performed.
In sixteen clearance studies, maleic acid (25 mg/kg body wt)
was intravenously administered over five minutes, and 18
consecutive 10-minute clearance periods were obtained. The
maleic acid was dissolved in normal saline and the pH of the
solution adjusted to 7.3 by the addition of 1 N NaOH. Any
changes in urine flow were matched by a corresponding change
in the rate of hypotonic glucose infusion. In eight of these
studies, maleic acid was administered 120 minutes after sus-
tained phosphate loading was initiated. A solution of neutral
sodium phosphate (pH 7.40, Na 161 mEq/liter, phosphorus
0.090 MmlmI) was intravenously administered at a rate of 3 to 6
ml/min for the first 60 minutes and at 3.0 to 1.5 mi/ruin for the
remainder of the experiment. Three consecutive clearance
periods were obtained immediately before administration of
maleic acid.
In five clearance studies, maleic acid was administered 120
minutes after sustained loading with sodium sulphate (three
studies) or sodium chloride (two studies) was initiated. A
solution of neutral sodium sulphate (Na + 161 mEq/liter, pH 7.4)
or normal saline was intravenously administered in a protocol
similar to that used for sodium phosphate loading. The rates of
infusion of sodium sulphate or sodium chloride were equivalent
to that of sodium phosphate used in the phosphate loading
studies.
In two clearance studies, acetazolamide (5 mg/kg body wt)
was intravenously administered as a bolus and maintained
thereafter at a rate of 5 mg/kglhr, and eighteen 10-minute
clearance periods were obtained.
Analytical methods
Urine samples were immediately analyzed manometrically
for total CO2 content using a Natelson microgasometer. Urine
and plasma were analyzed for inulin, Na, K, Cl-, P04,
alpha—amino nitrogen and citrate using techniques previously
described [281. On blood samples obtained via percutaneous
puncture of the femoral artery, blood pH and PCO2 were
measured with a Corning model 365 blood gas meter (Corning,
Midfield, Massachusetts, USA).
Lysosomal enzymes
An aliquot of urine from each collection period was immedi-
ately buffered to pH 6 (0.3 M citrate, I M NaCl, pH 6.0) and
refrigerated. At the end of the experiment, samples were
prepared for enzyme assays by dialysis overnight against 0.03 M
citrate buffer (pH 6.0, containing 0.1 M NaCl). Assays of the
three enzymes studied were based on the fluorometric measure-
ment of 4-methylumbelliferone liberated from the appropriate
glycoside, as described by Piagen and Peterson [29]. Assays
were performed in duplicate the day after the experiment.
Fluorescence was measured in an Aminco-Fluoro-colorimeter
equipped with interference filter for excitation at 371 n and
emission at 456 nM. Included in each series of assays were a
4-methylumbelliferone standard (1 nmol) and an enzyme stan-
dard, a 1/10 dilution of 10% homogenate of mouse liver pre-
pared in 0.25 M sucrose containing 0.02 M imidazole buffer.
Enzyme excretion rates were calculated by multiplying the
enzyme activity (nanomoles of product formed per minute per
ml) by the urinary flow rate (ml/minute) and expressed as
units/minute.
Lysozymes
An aliquot of urine and plasma from each collection period
were taken for measurement of lysozyme concentration. Sam-
ples were immediately frozen until the time of analysis, usually
within seven days after the day of the experiment. Lysozyme
concentration was determined by the lysoplate method as
described by Osserman and Lowlor [30], using purified human
lysozyme as standard. All samples were assayed in duplicate.
Serum concentration of lysozyme is expressed as p.g/ml and
urinary excretion rate was calculated by multiplying urinary
lysozyme concentration (g/ml) by urinary flow rate (mI/mm)
and expressed as pg/minute.
Statistical analysis
The significance of differences between means was per-
formed by 2 x 2 factorial analysis of variance with repeated
measures for eight dogs (maleic acid alone) versus eight dogs
(phosphate + maleic acid), and five dogs (sulphate or sodium
chloride + maleic acid). All statistical calculations were done
using a computer program provided as part of an SAS system
(SAS Institute, Cary, North Carolina, USA).
Results
Within 30 minutes of its administration, maleic acid induced
a complex dysfunction of the renal tubule like that of type 2
renal tubular acidosis and Fanconi syndrome, as evidenced by
striking increases in the renal clearance of bicarbonate,
alpha—amino nitrogen, phosphate, Nat, and K (Table 1).
Urinary excretion of citrate also strikingly increased within 30
minutes after administration of maleic acid, and this increment
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Fig. 1. Renal clearance (mi/mm) of bicarbonate (•CHcoj), alpha—ami-
no nitrogen (YCaAn, left scale), and lysozyme (AC lysozyme, right
scale) before (open symbols) and after (closed symbols) administration
of maleic acid. Values are the mean SEM, N = 8.
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Table 1. Effect of intravenous administration of maleic acid alone and after intravenous loading with sodium phosphate or sodium sulphate and
sodium chloride
Urine
GFR V
mi/mm mi/mm UPH
UNaV
sEqImin
UKV
p.Eq/min
UHcoV
p.Eq/min
U,,ANV
pEqimin
Maleic acid alone, N = 8
73 6 10.4 0.2 6.50 0.05 25 4 25 3 38 3 76 6
MA5 61 7 13.8 0.4 7.53 0.02 259 30 126 11 264 12 182 13
Sodium phosphate + maleic acid, N 8
C 74 6 10.2 0.6 6.52 0.10 37 12 22 2 44 5 74 6
P04c 75 7 11.3 0.5 6.48 0.09 259 87 74 Ii 56 11 70 9
MA 72 6 12.5 0.7 7.30 0.05 475 68 111 8 210 23 94 14
Sodium sulphate, N = 3, or sodium chloride, + maleic acid, N = 2 28±7 28±3 38±5 67±4C 73±8 8.9±0.9 6.32±0.18
SO4 or 73 9 10.0 0.9 5.51 0.06 242 55 82 12 72 18 66 6
NaCl4
MA 62 2 15.0 0.5 7.41 0.07 728 46 135 16 296 43 165 21
a c, values are the mean SEM of three to five consecutive 10-minutes clearance periods during control observation
b MA, values are the mean SEM of twelve consecutive 10-minutes clearance period beginning 60 minutes after administration of maleic acid
P04, values are the mean SEM of three consecutive 10-minutes clearance periods throughout sodium phosphate infusion immediately before
administration of maleic acid
d SO4, values are the mean SEM of three consecutive 10-minutes clearance periods throughout sodium sulphate infusion before administration
of maleic acid
a the studies in which maleic acid was administered after sodium sulphate or sodium chloride are combined
Table 1. Continued
Urine
Up04V UatrataV
UNAGV
,ug/min prnol/min
Un.eiuaV UgaiacV Uiozy,,,eV
p.g/min pHunit/mm
Maleic acid alone, N = 8
C 6 2 0.37 0.03 7.8 3.0 1.4 0.32 .44 0.13 1.5 0.13 7.40 0.01
MA 182 40 3.96 0.40 150.2 32 35.4 6.8 4.2 1.0 81.2 32 7.36 0.02
Sodium phosphate + maleic acid, N = 8
C 14 4 0.32 0.05 7.7 1.0 1.3 0.21 0.4 0.11 1.7 0.2 7.39 0.01
P04 6106 1225 0.31 0.04 7.1 1.5 1.4 0.27 0.36 0.10 1.5 0.21 7.43 0.01
MA 5729 1175 3.87 0.40 22.1 7 5.6 1.6 0.73 0.25 30.0 18 7.42 0.02
Sodium sulphate + MA, N 3; sodium chloride MA, N = 2
1.5 0.17 0.4 0.1 2.5 0.60 7.39 0.01C 4 2 0.19 0.05 7.4 0.7
SO4 4 3 0.20 0.03 6.0 0.8 0.8 0.06 0.3 0.03 2.5 0.81 7.42 0.01
MA 171 33 4.4 0.80 135 53 32.9 9.1 3.1 1.4 67.0 25 7.38 0.01
Table 1. Continued
Arterial blood Plasma
HCO3 Na K P04 nAN Citrate Lysozyme
mmol/liter mEq/liter mEq/liter mg/dl mg/dI jmo1/1 g/ml
Maleic acid alone, N = 8
C 22.0 0.8 137 2 3.51 0.13 2.1 0.2 2.6 0.2 0.20 0.03 2.0 0.20
MA 19.0 1.2 135 2 3.23 0.06 1.6 0.1 2.3 0.1 0.21 0.03 2.14 0.37
Sodium phosphate + MA, N 8
C 21.0 0.4 136 1 3.30 0.08 2.3 0.1 2.8 0.2 0.20 0.01 2.2 0.26
P04 23.4 0.5 140 1 3.26 0.10 12.1 2.0 2.7 '- 0.2 0.190 0.01 2.1 0.17
MA 22.0 0.7 143 2 3.01 0.09 12.0 1.6 2.4 0.1 0.196 0.02 1.90 0.23
Sodium sulphate + MA, N = 3; sodium chloride + MA, N = 2
2.0 0.2 3.1 0.2 0.20 0.04 2.0 0.21C 22.0 0.8 139 3 3.38 0.23
So4 22.5 1.3 141 2 3.54 0.25 2.0 0.2 3.1 0.2 0.20 0.04 2.0 0.21
MA 20.6 0.7 144 2 3.21 0.14 1.8 0.2 2.5 0.2 0.21 0.03 1.90 0.22
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occurred without significant change in plasma concentration of
citrate. Glomerular filtration rate decreased by a mean of 16%
(Table 1). The severity of the dysfunction became maximal 120
to 140 minutes after administration of maleic acid and persisted
largely unchanged for the subsequent 40 to 60 minutes (Fig. I).
Sixty minutes after administration of maleic acid, urinary
excretion of lysozyme increased and continued to increase
progressively thereafter, reaching a maximal value 40-fold
greater than control value within 120 to 140 minutes after
administration of maleic acid. Subsequently, while the magni-
tudes of the increases in urinary excretion and renal clearance
of bicarbonate, alpha—amino nitrogen and sodium continued
undiminished, urinary excretion of lysozyme progressively
decreased, the value at 180 minutes having decreased to ap-
proximately one—half that attained at 140 minutes (Table I,
Figs. 1 and 2). Plasma concentration of lysozyme did not
change significantly after administration of maleic acid.
Sixty minutes after administration of maleic acid and approx-
imately 30 minutes after the occurrence of FS/RTA2, urinary
excretion rate of NAG increased and continued to increase
progressively, reaching a maximal value 22-fold greater than the
control value within 120 to 140 minutes after administration of
maleic acid, Thereafter, NAG excretion rate progressively
decreased, the value at 180 minutes having decreased to ap-
proximately one-half of the maximal value attained at 140
minutes (Table 2 and Figure 2). The onset and the pattern of the
maleic acid—induced increment in urinary excretion of NAG
was nearly identical to that of lysozyme (Figures 2 and 3).
Similarly, within 60 minutes after administration of maleic acid,
urinary excretion rates of /3-glucuronidase and /3-galactosidase
progressively increased reaching maximal values within 120 to
140 minutes after administration of maleic acid. Thereafter,
urinary excretion of these two enzymes progressively de-
creased. The onset and patterns of the maleic acid—induced
increments in urinary excretion of these two enzymes were
nearly identical to that of NAG (Fig. 4). Although the absolute
excretion rates (units/mm) of NAG, /3-glue, and /3-galac all
increased and subsequently decreased after administration of
maleic acid, the ratio of excretion rate of one enzyme to another
remained relatively constant (Table 2). Thus, maleic acid in-
duced a coordinate increase in urinary excretion of lysosomal
120 enzymes.
Prior phosphate loading, which increased the plasma concen-
tration of inorganic phosphate to 12.1 2 mgldl, strikingly
attenuated the severity of not only the FS/RTA2 but also the
60 severity of the lysozymuria and the lysosomal hyperenzymuriainduced by subsequent administration of maleic acid (Table 1,
middle panel, Table 3, and Fig. 2). When maleic acid was
administered alone, urinary excretion of NAG increased from
7.8 3.0 to 150.2 32.0 U/mm. With prior phosphate loading,0 administration of maleic acid induced an increase in the urinary
excretion of NAG from 7.1 1.5 to 22.1 7.0 U/mm, an
increment significantly less than that occurring with maleic acid
alone. Similarly, prior phosphate loading significantly attenu-
ated the maleic acid—induced increments in urinary excretion of
/3-glue and f3-galac (Tables 1 and 3, Fig. 5). When maleic acid
was administered alone, urinary excretion rates of lysozyme
strikingly increased from 1.5 0.13 to 81.2 32 j.tg/min, but
with prior phosphate loading, urinary excretion of lysozyme
increased from 1.5 0.21 to 30 18 g/min, an increment
strikingly less than that occurring with maleic acid alone (Table
I and 3, Fig. 2). With prior phosphate loading, the maleic
acid—induced increments in renal clearance and fractional
excretion of bicarbonate and alpha—amino nitrogen were signif-
icantly less than those attained when maleic acid was adminis-
tered alone (Tables 1 and 3). The maleic acid—induced incre-
ment in renal clearance of citrate was not affected by prior
phosphate loading. Urinary excretion of citrate increased from
0.37 0.03 to 3.96 0.4 smolImin when maleic acid was
administered alone, and from 0.31 0.04 to 3.87 0.4 mollmin
when maleic acid was administered after phosphate loading
(Table 3). Sodium phosphate loading alone induced the charac-
teristic effect of sodium salt containing a non-reabsorbable
anion: fractional excretion (FE) of Na amd K both in-
creased, whereas that of Cl- decreased (data are not shown).
GFR, urinary pH, urinary excretion of bicarbonate, alpha—
amino nitrogen, citrate, lysozyme, and lysosomal enzymes did
not change.
The severity of the RTA2/FS and the magnitude of the
increase in urinary excretion of lysosomal enzymes and
lysozyme induced by maleic acid were not affected by prior
loading with sodium sulphate or sodium chloride (Tables 1 and
3). Administration of sodium sulphate alone induced the pre-
dictable effect of nonreabsorbable anion [311 as evidenced by
significant reduction in urinary pH and FEC1 and significant
increase in FENa and FEK (as great as those induced with
phosphate loading). Urinary excretion of lysozyme and
lysosomal enzyme did not change. However, subsequent ad-
ministration of maleic acid increased the urinary excretion of
lysozyme from 2.5 0.81 to 67.0 25 sg/min, and urinary
excretion of NAG increased from 362 48 to 8111 3175
U/mm, an increment not different than those induced after
administration of maleic acid alone. Similarly, the maleic
acid—induced increments in urinary excretion rates of /3-glue
and /3-galac were not affected by prior sulphate loading. With
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Fig. 2. Urinary excretion of lysozyme (A p.g/min, right scale) and
N-acetyl-/3-glucosaminidase (NAG, U U/mm, left scale) before (open
symbols) and after (circled symbols) intravenous administration of
maleic acid alone (8 studies) or after sodium phosphate loading (8
studies, circled symbols). Values are the mean SEM.
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Table 2. Effect of administration of maleic acid on lysosomal enzyme excretion and the ratio of excretion of one enzyme to another in
representative studies in two dogs
Dog#1 Dog#2
NAG" /3-glue" /3-galac"
NAG/f3g1uC NAG/I3-galac'1
NAG /3-glue /3-galac
NAG//3-gluc /3-gluc/f3-galacTime unit/mm unit/mm
—30 to 20 5.4 1.4 0.18
-10 to 0 6.9 1.9 0.22
Maleic acid 25 mg/kg iv. over 5 minutes
3.85
3.63
1.0
4.0
3.34
3.54
3.26
3.46
3.88
3.88
—
30.0
31.3
46.0
40.6
27.8
26.3
47.0
45.4
46.9
47.0
—
3.1
3.9
2.7
2.6
3.7
23.7
270.4
576.3
542.9
208.8
169
0.58
0.68
0.33
0.26
0.47
5.4
60.3
152.3
147.3
47.0
36.8
0.11
0.13
0.12
0.11
0.13
0.52
3.93
9.06
8.96
4.06
2.76
5.34
5.73
8.18
10.0
7.87
4.38
4.48
3.78
3.68
4.44
4.59
28.18
29.75
22.5
23.63
28.46
45.57
68.8
63.6
60.59
51.4
61.2
0—20 2.3 2.1 0.05
20—40 6.5 1.6 0.16
40—60 27.8 8.3 1.0
60—80 33.7 9.5 1.28
80—100 62.1 19 1.32
100—120 102.6 29.6 2.26
120—140 117.8 30.3 2.51
140—160 82.3 21.2 1.75
160—180 — — —
C Values are the average of two consecutive clearance periods. Abbreviations are: NAG, N-acetyl-glucosaminidase; /3-glue, f3-glucuronidase; [3-
galac, /3-galactosidase
h Enzyme excretion rate (unit/minutes)
C Ratio of excretion of NAG to /3-glucuronidase
' Ratio of excretion of NAG to /3-galactosidase
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Fig. 3. Time course of the maleic acid—induced increases in urinary
excretion of NAG (U), lysozyme (A), alpha—a,'nino nitrogen (V), and
sodium (). Values are expressed as the percent of the maximal
excretion rates attained after administration of maleic acid.
prior sulphate loading, the magnitude of the maleic acid—
induced increases in renal clearance of bicarbonate and alpha
amino—nitrogen were not different from those occurring with
maleic acid alone (Table 1, lower panel). Prior loading with
sodium chloride, which induced some degree of volume expan-
sion as evidenced by an increase in urine flow rates, FENa and
FEK had no effect on the severity of the FS/RTA2 or the
magnitude of the lysosomal and lysozymal enzymuria induced
by maleic acid.
Administration of acetazolamide, which increased the frac-
tional excretion of bicarbonate from 4.0 1 to 28 2%, an
increment as great as that induced by maleic acid, induced no
changes in the urinary excretion of lysosomal enzymes or
lysozyme. Accordingly, these findings provide evidence that
maleic acid induces the increases in urinary excretion of
lysozyme and lysosomal enzymes through a mechanism that
1,660
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Fig. 4. Urine flow (x) and urinary excretion of N-acetyl-3-glucosamini-
dase (U), [3-glucuronidase (•), and f3-galactosidase (*) before (open
symbols) and after (closed symbols) administration of maleic acid in 8
dogs. Values are the mean. Data are plotted on a semilog basis. Parallel
lines indicate relatively constant enzyme excretion ratios.
involves more than a dysfunction of the proximal tubule in
which this segment reabsorbs NaHCO3 and Cl at greatly
reduced rates [321.
—30 --10 0 20 40 60 80 100 120 140 160 180
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Table 3. Comparison of changes in renal function and urinary excretion of enzymes induced by administratio
administration of sodium phosphate or sodium sulphate
n of maleic acid alone and after
Na
Absolute changes from controla
GFR CHCO3 C,AN Ccitrate Ciy,ozyme UNAGV U10V UpgaiacV
mI/mm unit/mm
P04 +
SO., +
MA
MA
MA
8
8
5
—12 3
—3 l
—11.5 3
10.8 1.1 5.7 0.65 21.0 2 32.0 9 142 30
6.3 0.6C 1.1 0.50e 22.0 3 12.7 9" 15.4 6d
11.2 2 5.3 1.2 20.2 4 31.0 16 129 52
34 6.843 l.55'
32 9.1
3.7 0.9
0.42 0.20"
2.8 1.45
Abbreviations are: MA, changes induced after administration of maleic acid alone; PU4 + MA, changes induced after administration of maleic
acid during sodium phosphate loading; SO4 + MA, changes induced after administration of maleic acid during sodium sulphate or sodium chloride
loading.
a Values are the means SEM of the difference between control and experimental values. For each study, a control value was calculated as the
mean of three 10-minute clearance periods immediately preceding administration of maleic acid. An experimental value was calculated as the mean
of twelve 10-minute clearance period beginning 60 minutes after administration of maleic acid.b Significantly different when compared with the changes induced by administration of maleic acid alone (analysis of variance) P <0.02
C < 0.01d P < 0.005
e P < 0.002 Changes induced by administration of maleic acid during sodium sulphate loading are not significantly different from those induced
by administration of maleic acid alone.
Fig. 5. Urine flow (X) and urinaly excretion of N-acetyl-f3-glucosami-
nidase (s), 13-glucuronidase (S), and f3-galactosidase ( before (open
symbols) and after (closed symbols) administration of maleic acid after
sodium phosphate loading in 8 dogs. Values are the mean. Data are
plotted on a semilog basis. Parallel lines indicate relatively constant
enzyme excretion ratios.
Discussion
The current studies show that in the dog, as in the rat,
parenterally—administered maleic acid acutely induces not only
the reabsorptive renal dysfunction of FS/RTA2 [33—37], but also
a reduction in the net rate at which the renal tubule reabsorbs
lysozyme [4J. Urinary excretion and renal clearance of
lysozyme increased strikingly without change in the plasma
concentration of lysozyme. In the current study employing the
trained unanesthetized dog, the transepithelial transport dys-
functions of FS/RTA2 became apparent 30 minutes after admin-
istration of maleic acid, became maximal in severity 90 to 110
minutes afterward, and persisted either unchanged or undimin-
ished in severity over the subsequent 40 to 60 minutes. The
results of the current studies demonstrate that: 1) the increase
in renal clearance of lysozyme began some 30 minutes after the
20 onset of the dysfunction of FS/RTA2; 2) simultaneously with
the onset of the lysozymuria there occurred an abrupt increase
in urinary excretion of NAG and other lysosomal enzymes,
/3-gluc and /3-galac; 3) from the onset of the increased excretions
of lysozyme and lysosomal enzymes, the magnitudes of these
< hyperenzymurias increased not only rapidly and progressively,
10 but also in parallel, all reaching a peak some 60 to 80 minutes
after their onset; 4) thereafter, while the severity of the
FS/RTA2 continued undiminished, the severity of all of these
hyperenzymurias decreased not only rapidly, greatly and pro-
gressively, but also in parallel; and 5) throughout the
hyperenzymurias, the excretion of NAG was coordinate with
that of other lysosomal enzymes, specifically, the ratio of the
rate of excretion of NAG to that of other lysosomal enzymes,
/3-gluc and f3-galac, remained relatively constant. Thus, the time
courses of the increased excretions of NAG, /3-gluc, and /3-gala
are indistinguishable not only from each other, but also from
that of lysozyme, yet clearly distinct from those of bicarbonate,
amino acids, and sodium. The results indicate that in the maleic
acid—induced renal tubular disorder expressed as FS/RTA2,
there occurs a profound, but rapidly reversing derangement in
the renal tubular processing of proteins that affects not only
those that are normally filtered by the glomerulus and
endocytosed by the cells of the proximal tubule, but also those
that are normally synthesized within cells of the renal tubule
and segregated in their lysosomes. The results provide evidence
that in the renal tubular disorder induced by maleic acid, the
complex derangement in the renal handling of proteins is to
some extent functionally separable from the transepithelial
transport dysfunctions of FS/RTA2 and that the impairment in
reabsorption of lysozyme can not, as has been suggested [4], be
mediated solely by the reduction in renal tubular reabsorption
of sodium. The results of the present study suggest that the
derangement in renal handling of lysozyme is in some way
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functionally linked to a derangement in renal processing of
lysosomal enzymes.
The maleic acid—induced increase in urinary excretion of
lysosomal enzymes can not be readily ascribed to an increased
permeability of the glomerular membrane to circulating lyso-
somal enzymes. Even when administered in large amounts,
maleic acid does not induce either an alteration in the ultra-
structure of the glomerulus [38] or an increase in the renal
clearance of various sizes of polyvinylpyrrolidone [3]. The
structural disorder of the vacuolar—lysosomal system induced
by maleic acid in the kidney appears to be restricted to the
proximal tubule [10]. In the kidney, NAG occurs predominantly
in the lysosomes of the proximal tubule [14, 15] and clearly,
urinary NAG can originate exclusively from the kidney [39].
Even in renal disorders that affect the glomerulus (and are not
hematuric), the lysosomal enzymes excreted in the urine in
increased amounts do not appear to originate predominantly
from the serum [40—43]. Accordingly, we conclude that the
maleic acid—induced increment in urinary excretion of NAG
and other lysosomal enzymes reflects an increased rate at which
these enzymes exit cells of the renal tubule, and probably
mainly from those of its proximal segment.
It has generally been inferred that in most, if not all, renal
disorders, acute as well as chronic, the finding of an increased
urinary excretion of lysosomal enzymes reflects "damage" or
"injury" to the renal tubular cells [16—18]. This inference is
based on two tacit assumptions: 1) lysosomal enzymes exit cells
of the renal tubule at increased rates only when they leak from
lysosomes of these cells into the tubular lumen at increased
rates; and 2) such leakage can occur only when the membrane
of lysosome has been structurally disrupted or rendered abnor-
mally permeable to lysosomal enzymes as a part of a more
general damage or injury to cells of the renal tubule. But, in a
variety of cells, increased rates of exocytosis of lysosomal
enzymes can be acutely induced without inducing concomitant
"damage" or "injury" to these cells [26, 27, 44]. Furthermore,
in ultrastructural and biochemical studies in the normal female
mouse, Koenig, Goldstone and Hughes [19] demonstrated that
chronic administration of testosterone induced restrictively in
the renal proximal tubule a striking accumulation of enlarged
lysosomes and an increased exocytosis of these lysosomes into
the lumen of the proximal tubule. Coincident with these phe-
nomena, the urinary excretion of the lysosomal enzymes,
NAG, p-glue, and p-gala strikingly and progressively increased.
These investigators concluded that testosterone induced an
accelerated rate of exocytotic release of lysosomes and their
contents from proximal tubular cells into the tubular lumen.
Thus, an increase in the rate of exocytosis of lysosomal
enzymes from the cells of the renal tubule can underlie in-
creased rates of excretion of these enzymes, and such an
increase can be induced without inducing "damage" or "in-
jury" to cells of the renal tubule.
Mere damage of the renal tubular cells does not readily
explain the observation that the lysosomal hyperenzymuria
induced by maleic acid is strikingly coordinate with the
lysozymuria induced by this agent. Not only is the lysosomal
hyperenzymuria coordinate with respect to its onset and peak
of severity, but also with respect to the course of its rapid
reversal. It might be argued that acute damage to lysosomes of
acutely "damaged" renal tubular cells could simultaneously
impair both the lysosomes's containment of lysosomal enzymes
and the reabsorption of lysozyme, given the fact that the
lysosome is the normal terminus in the renal tubular reabsorp-
tion of lysozyme. If maleic acid merely damaged the renal
tubular cells so that they reabsorbed lysozyme at greatly
reduced rates and leaked lysosomal enzymes (from damaged
lysosomes) at greatly increased rates, it seems unlikely that
cells so damaged would abruptly, simultaneously, and to the
same considerable extent, both rapidly increase the rate at
which they reabsorb lysozyme, and rapidly reduce the rate at
which they "leak" lysosomal enzymes from their lysosomes.
Thus, we would not infer that the maleic acid—induced
lysosomal hyperenzymuria reflects only release of lysosomal
enzymes from "damaged" lysosomes of "damaged" renal
tubular cells. Nor would we infer that the maleic acid—induced
lysozymuria reflects just another reabsorptive defect in the
proximal tubule. Rather, we would propose that the lysosomal
hyperenzymuria induced by maleic acid reflects, at least in part,
a reversible functional derangement in the renal processing of
lysosomal enzymes, and that such a derangement is in some
way mechanistically linked to the reversible functional derange-
ment in renal tubular processing of lysozyme. It is possible that
the time course of the coordinate hyperenzymurias could reflect
increased rates of lysosomal discharge of both lysosomal en-
zymes and already reabsorbed lysozyme.
In the proximal renal tubule of rat given maleic acid,
Christensen and Maunsbach [101 found not only an impairment
in endocytosis of lysozyme and its transport to, and degradation
in, the lysosome, but also morphological alterations in the
major components of the vacuolar system, including not only
the lysosomes, but also the apical tubules. Whereas endocytic
vacuoles accumulated, the apical tubules disappeared [10]. If,
as recent evidence suggests, apical tubules function to return
membrane material from the endocytic vacuoles to the luminal
plasma membrane [45], the maleic acid—induced disappearance
of the apical tubules may indicate altered recycling of mem-
brane as originally suggested by Maunsbach [81. In a variety of
cells, the processes of endocytosis and exocytosis are coupled
[20—25] such that the two processes constitute opposing limbs of
a cyclic continuum in which membrane fragments of endocy-
totic vacuoles are rapidly recycled to the exocytotic vacuoles
and to the plasma membrane, In isolated polymorphonuclear
leukocytes, inhibition of endocytosis by cytochalasin B is
attended by fusing of lysosomes to the plasma membrane and
increased release of lysosomal enzymes into the medium when
these cells are exposed to zymosan [261. In normal fibroblasts,
chloroquine induced not only an increase in rates of exocytosis
of newly synthesized lysosomal enzymes, but also an impair-
ment in endocytosis of exogenous lysosomal enzymes, a phe-
nomenon that has been attributed to an impairment in receptor
recycling [27]. Thus, in the acute FS/RTA2 induced by maleic
acid, coupling of endocytosis to exocytosis (and hence mem-
brane recycling) may be so deranged that the impairment in
endocytosis induced by maleic acid entrains an accelerated
exocytosis of lysosomal enzymes.
In the proximal renal tubule, the vacuolar transport system,
like transepithelial transport, is energy dependent [9, 46]. Renal
tubular uptake of lysozyme is decreased in a dose dependent
fashion by metabolic inhibitors such as cyanide [9]. Maleic acid
is known to inhibit renal mitochondrial oxidative metabolism
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[35, 47] and to induce a reduction in renal cortical concentration
of ATP [48—50]. Christensen and Maunsbach [10] suggested that
the maleic acid—induced reduction in the endocytotic uptake of
lysozyme and its transport from endocytotic vacuoles to the
lysosomes is "likely due to lack of energy supplies in the form
of ATP". The current finding that the maleic acid—induced
increased urinary excretion of lysozyme is coordinate with that
of lysosomal enzymes suggests the possibility that a disorder in
mitochondrial oxidative metabolism underlies the increased
urinary excretion of both lysozyme and lysosomal enzymes.
In recent studies [51] we found that the FS/RTA2 induced by
maleic acid is attenuated by prior phosphate loading. In the
current study, we found that phosphate loading also attenuates
the increased urinary excretion of lysozyme and lysosomal
enzymes, each to the same extent, and so without changing
their pattern of coordinate excretion. Phosphate loading atten-
uates the seventies of the bicarbonaturia and aminoaciduria,
but not that of the citraturia. The magnitude of the maleic
acid—induced increases in urinary excretion of lysozyme and
lysosomal enzymes, like the FS/RTA2, was not attenuated by
administration of sodium sulphate or sodium chloride in
amounts equimolar to that of sodium phosphate and causal of
non-reabsorbable anion effects and volume expansion, respec-
tively, as great as those induced by sodium phosphate. Accord-
ingly, these findings provide evidence that the attenuating effect
of phosphate loading depends on some effect of phosphate ion
per se, and suggest that a phosphate dependent metabolic
abnormality in cells of the proximal tubule participates in the
pathogenetic mechanisms of both the FS/RTA2 and the de-
rangement in renal tubular processing of proteins induced by
maleic acid.
On the basis of several line of evidence, including Berliner's
original observation [33, 52, 53], we have proposed that the
pathogenetic mechanism of the maleic acid—induced FSIRTA2
involves a positive feedback loop in cells of the proximal
tubule: impaired mitochondrial oxidative metabolism — in-
creased glucose uptake and rate of glycolysis —+ accumulation
of phosphorylated glycolytic intermediates — limitation on the
availability of inorganic phosphate —+ further impairment in
mitochondrial oxidative metabolism. That operation of such a
loop can participate in the pathogenetic mechanisms of both
FS/RTA2 and the disorder in renal processing of proteins
induced by maleic acid is suggested by the observations that
both are attenuated by phosphate loading and exacerbated by
glucose loading [541.
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